January 17, 2023
2 min watch
Save
VIDEO: ViaLase’s femtosecond laser shows positive safety, efficacy data
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Shawn O’Neil of ViaLase discusses positive 24-month safety and efficacy data for the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.
The laser showed no adverse events at 2 years, as well as a median IOP lowering of 32% in a case series of 17 eyes, he said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
O’Neill is chief commercial officer of ViaLase.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.